Department of Nuclear Medicine, Beijing Chaoyang Hospital, Capital Medical University, 8th Gongtinanlu Road, Chaoyang District, Beijing, 100020, China.
Department of Magnetic Resonance Imaging, Fuwai Hospital, National Center for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Eur J Nucl Med Mol Imaging. 2023 Dec;51(1):110-122. doi: 10.1007/s00259-023-06411-0. Epub 2023 Aug 29.
This study aimed to evaluate the functional significance of F-labeled fibroblast activation protein inhibitor (F-FAPI) activity in hypertrophic cardiomyopathy (HCM) by comparison with cardiac magnetic resonance feature-tracking (CMR-FT) strain analysis.
A total of 49 HCM patients were included in this study. Two independent control groups of healthy participants with a matched age and sex to the HCM patients were also enrolled. Left ventricular (LV) F-FAPI activity was analyzed for extent (FAPI%) and intensity (maximum target-to-background ratio, TBR). The CMR tissue characterization parameters of the LV included late gadolinium enhancement, native T1 value, and extracellular volume fraction. LV strain analysis was performed in radial, circumferential, and longitudinal peak strains (PS).
Intense LV myocardial F-FAPI uptake was observed in HCM patients, whereas no obvious uptake was detected in healthy participants (median TBR, 9.1 vs. 1.2, p < 0.001). The strain parameters of HCM patients, compared with healthy participants, were significantly impaired (mean radial PS, 23.5 vs. 36.0, mean circumferential PS, -14.5 vs. -20.0, and mean longitudinal PS, -9.9 vs. -16.0, all p < 0.001). At segmental levels, there was a moderate correlation between F-FAPI activity and strain parameters. The number of positive F-FAPI uptake segments (n = 653) was higher than that of hypertrophic segments (n = 190) and positive CMR tissue characterization segments (n = 525) (all p < 0.001). In segments with negative CMR tissue characterization findings, the strain capacity of positive F-FAPI uptake segments was lower than that of negative F-FAPI uptake segments (median radial PS, 30.5 vs. 36.1, p = 0.026 and median circumferential PS, -18.4 vs. -19.7, p = 0.041).
F-FAPI imaging can partially reflect the potential strain reduction in HCM patients. F-FAPI imaging detects more involved myocardium than CMR tissue characterization techniques, and the additionally identified myocardium has impaired strain capacity.
本研究旨在通过比较心脏磁共振特征追踪(CMR-FT)应变分析,评估 F 标记成纤维细胞激活蛋白抑制剂(F-FAPI)活性在肥厚型心肌病(HCM)中的功能意义。
共纳入 49 例 HCM 患者,同时纳入与 HCM 患者年龄和性别相匹配的两组健康对照者。分析左心室(LV)F-FAPI 活性的范围(FAPI%)和强度(最大靶背比,TBR)。LV 的 CMR 组织特征参数包括延迟钆增强、原生 T1 值和细胞外容积分数。在径向、环向和纵向峰值应变(PS)中进行 LV 应变分析。
HCM 患者的 LV 心肌 F-FAPI 摄取明显增强,而健康对照者无明显摄取(中位数 TBR,9.1 比 1.2,p<0.001)。与健康对照者相比,HCM 患者的应变参数明显受损(平均径向 PS,23.5 比 36.0,平均环向 PS,-14.5 比-20.0,平均纵向 PS,-9.9 比-16.0,均 p<0.001)。在节段水平上,F-FAPI 活性与应变参数之间存在中度相关性。F-FAPI 摄取阳性节段数(n=653)高于肥厚节段数(n=190)和阳性 CMR 组织特征节段数(n=525)(均 p<0.001)。在 CMR 组织特征表现为阴性的节段中,F-FAPI 摄取阳性节段的应变能力低于 F-FAPI 摄取阴性节段(中位数径向 PS,30.5 比 36.1,p=0.026 和中位数环向 PS,-18.4 比-19.7,p=0.041)。
F-FAPI 成像可部分反映 HCM 患者潜在的应变减少。F-FAPI 成像检测到的心肌受累范围大于 CMR 组织特征技术,且额外识别的心肌应变能力受损。